-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Gain Therapeutics, Inc. quarterly and annual Net Cash Provided by (Used in) Investing Activities history and change rate from Q1 2020 to 2024.
- Gain Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2024 was $3,018,750, a 43% increase year-over-year.
- Gain Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $4,977,507, a 51% decline from 2023.
- Gain Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $10,222,667.
- Gain Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $14,774,813, a 15583% decline from 2021.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)